The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Impact of axillary lymph node dissection on the therapy of breast cancer patients.
Abstract
PURPOSE: We studied a series of 283 breast cancer patients retrospectively to determine the actual benefits of axillary lymph node dissection (ALND) for these patients. PATIENTS AND METHODS: The records of 283 women with invasive breast cancer treated between 1988 and 1990 were reviewed for histologic status of the axillary lymph nodes, tumor size, DNA content, hormone-receptor values, and actual adjuvant treatments received. RESULTS: ALND was of possible therapeutic benefit for the 15% (43 of 283) of patients who had clinically positive nodes. Nodal metastases were found in 86% (37 of 43) of patients in this subgroup. ALND alone determined the indication for standard adjuvant therapy for a group of 31% (88 of 283) of patients who had favorable primary biopsy findings and clinically negative axillary nodes; ALND proved that 13% (11 of 88) of these latter patients had positive nodes. For 54% (152 of 283) of patients who had clinically negative nodes and unfavorable biopsies, ALND played no role in the decision as to whether standard adjuvant therapy was indicated. Only 5% (seven of 152) and 3% (four of 152) of these latter patients received radiation therapy and/or high-dose adjuvant chemotherapy, respectively, because of ALND. CONCLUSION: The benefits of ALND vary greatly for different groups of breast cancer patients, and controlled studies may be needed to determine whether ALND is necessary for all breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,464
Fisher, B., Redmond, C., Fisher, E. R., Bauer, M., Wolmark, N., Wickerham, D. L., Deutsch, M., Montague, E., Margolese, R., & Foster, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121102 · Cited by 1,376
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329
Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., et al. (1983) · Cancer · doi:10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3 · Cited by 1,034
Nemoto, T., Vana, J., Bedwani, R. N., Baker, H. W., McGregor, F. H., & Murphy, G. P. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m · Cited by 661
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
Clark, G. M., Dressler, L. G., Owens, M. A., Pounds, G., Oldaker, T., & McGuire, W. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903093201003 · Cited by 558
Treatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial
Atkins, H., Hayward, J. L., Klugman, D. J., & Wayte, A. B. (1972) · BMJ · doi:10.1136/bmj.2.5811.423 · Cited by 426
Fisher, B., Redmond, C., Fisher, E. R., & Caplan, R. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.7.1076 · Cited by 419
Larson, D., Weinstein, M., Goldberg, I., Silver, B., Recht, A., Cady, B., Silen, W., & Harris, J. R. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90280-4 · Cited by 374
Cited by
Wilke, L. G., McCall, L. M., Posther, K. E., Whitworth, P. W., Reintgen, D. S., Leitch, A. M., Gabram, S. G. A., Lucci, A., Cox, C. E., Hunt, K. K., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.013 · Cited by 580
Arm edema in breast cancer patients
Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., & Kahn, K. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.96 · Cited by 560
Incidence of breast carcinoma-related lymphedema
Petrek, J. A., & Heelan, M. C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+<2776::aid-cncr25>3.0.co;2-v · Cited by 462
Lymphedema: current issues in research and management
Petrek, J. A., Pressman, P. I., & Smith, R. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.5.292 · Cited by 283
Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study
Bahl, M., Ennis, M., Tannock, I. F., Hux, J. E., Pritchard, K. I., Koo, J., & Goodwin, P. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6654-9 · Cited by 80
Metadata
- Authors
- Lin, P. P., Allison, D. C., Wainstock, J., Miller, K. D., Dooley, W. C., Friedman, N., & Baker, R. R.
- Venue
- Journal of Clinical Oncology
- Published
- 1993-08
- Volume
- 11
- Issue
- 8
- Pages
- 1536-1544
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1907119325
- Cited by
- 277
- References
- 24
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of axillary lymph node dissection on the therapy of breast cancer patients. https://app.cochat.ai/papers/10.1200/jco.1993.11.8.1536
- The paper
- Lin, P. P., Allison, D. C., Wainstock, J., Miller, K. D., Dooley, W. C., Friedman, N., & Baker, R. R. (1993). Impact of axillary lymph node dissection on the therapy of breast cancer patients. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1993.11.8.1536
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
